Commercialization and Entrepreneurship in Translation

Welcome to the Commercialization and Entrepreneurship in Translation Program (CAET)

The Commercialization and Entrepreneurship Program (CAEP) is designed to harness the considerable expertise of the following organizations:

In addition, the Science Center of Philadelphia serves as a source of venture capital and a site of "incubator space" for scientists from all the partners in the CAEP.

Objectives:

  • To develop educational modalities, such as use of the ITMAT portal and elective courses within the MTR, and to highlight entrepreneurial opportunities;
  • To identify and address the hurdles that obstruct commercialization of discoveries made by clinical and translational research at the institution and to do the same for external collaborators;
  • To increase cooperation among institutions to enable the seamless transition for new technology through all steps from concept through commercialization;
  • To regionalize these educational and infrastructural initiatives via collaboration with BioAdvance and our strategic industrial partners, such as Siemens, Abbott Diagnostics, Johnson & Johnson, and Pfizer; and to foster research initiatives in innovation by catalyzing research interactions between the Wharton Business School and CTSA investigators.
  • To speed business development and process through unique collaborations.

CAET Key Personnel

Anne Rentoumis Cappola, MD, ScM
Director of CAEP, a member of the Mack Center and Managing Director, Office of Corporate Alliances, School of Medicine

Email: acappola@mail.med.upenn.edu